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1. Introduction 
Physical plasma is defined as a gas in which part of the particles that make up the matter are 
present in ionized form. This is achieved by heating a gas leading to dissociation of the 
molecular bonds and subsequently ionization of the free atoms. Thereby, plasma consists of 
positively and negatively charged ions and negatively charged electrons as well as radicals, 
neutral and excited atoms and molecules (Raizer, 1997; Conrads and Schmidt, 2000). On the 
one hand, plasma is a natural phenomenon as more than 90 % of the universe is in the 
plasma state, for example in fire, in the polar aurora borealis and perhaps most importantly 
in the nuclear fusion reactions of the sun. On the other hand, plasma can be created 
artificially and has found applications in technology like plasma screens or light sources. 
The use of high temperature plasma for energy production is still the focus of ongoing 
research. 
For the modification of biomaterial surfaces, low temperature plasma which is sometimes 
also called cold plasma is used. It is characterized by a low degree of ionization at low or 
atmospheric pressure (Roth, 1995; Roth 2001; Hippler et al., 2008). To create low temperature 
plasmas, a compound is first transformed into a gas and then ionized by applying energy in 
the form of heat, direct or alternating electric current, radiation or laser light. Commonly 
used plasma gas sources are oxygen, nitrogen, hydrogen or argon. Two typical research 
plasma reactors for different applications are shown in Fig. 1. Depending on the nature and 
amount of energy, low temperature plasmas are characterized by a non-equilibrium 
between electron temperature and gas temperature. Thus the main parameters which define 
the characteristics of a plasma and thereby its applicability are its temperatures, types and 
densities of radicals and its level of ionization. In material science, possible applications of 
low-temperature plasmas include the modification of surface properties like electrochemical 
charge or amount of oxidation as well as attachment or modification of surface-bound 
chemical groups. Consequently, properties like hardness, resistance to chemical corrosion or 
physical abrasion, wettability, the water absorption capacity as well as the affinity toward 
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specific molecules can be modulated specifically and precisely by the use of low-
temperature plasmas (Meichsner et al., 2011). 
 
    
Fig. 1. Laboratory-size low-temperature plasma reactors for argon / ethylenediamine 
plasma (left) and pulsed magnetron sputtering (right) 
Plasma treatments can be used to improve different aspects of the therapeutic characteristics 
of medical implants (Ohl & Schröder, 2008; Schröder et al., 2011). Possible applications 
include the incorporation of therapeutic agents into implants or the attachment of drug 
molecules onto the material surface. This includes for example plasma processes used for 
surface coupling of antibiotic substances or for integration of metal ions into biomaterial 
surfaces to create implants which exhibit long-lasting antibacterial properties after 
implantation. By creating such implants with antibacterial properties, the often devastating 
effects of implant-related infections could be markedly reduced. Therapeutic agents for 
other applications can be loaded onto implant surfaces via plasma treatment as well to 
achieve their controlled release over time. Possible applications are drug-eluting stents and 
vascular prostheses which release drugs to reduce blood coagulation and thombosis as well 
as to prevent intima hyperplasia and restenosis. 
Low-temperature plasma-modified surfaces were furthermore found to possess specific 
bioactive properties in vitro and in vivo. For example, such surfaces influence the 
attachment and growth of osteoblasts, fibroblasts and inflammatory cells which provides 
the possibility to enhance implant ingrowth and tissue regeneration as well as to reduce 
implant-related inflammation, thereby improving the biocompatibility. Another field of 
application is plasma sterilization of prosthetic materials which is a gentle approach that can 
be adapted for many different materials and which is especially advantageous over 
www.intechopen.com
 
Application of Low-Temperature Plasma Processes for Biomaterials 
 
129 
conventional methods regarding the required time. From a process technology point of 
view, sterilization would also be a beneficial concomitant effect of other plasma treatments 
aimed at modulating specific material properties. The range of materials which can be 
treated with low-temperature plasma processes includes many materials with an established 
track record in regenerative medicine, for example ceramics like hydroxyapatite, polymeric 
materials like polyester, polypropylene, silicone and polytetrafluoroethylene, and metals 
like titanium, titanium-based alloys and steel. Consequently, the possible utilization of 
plasma treatments in the field of biomaterials includes a wide range of applications in 
cardiovascular and reconstructive surgery, orthopaedics and dentistry. Therefore, low-
temperature plasma processes have great potential for improvement of medical implants. In 
the following, a concise overview of the respective applications and the underlying plasma 
processes is presented, putting an emphasis on recent developments. The main directions of 
research in this developing field are reviewed in terms of the respective aims, the relevant 
materials and the potential clinical applications. 
2. Plasma-assisted creation of implants containing therapeutic compounds 
The coating of implant surfaces with therapeutic agents is an interesting approach to improve 
the clinical outcome of implantation. In this field, the treatment with plasma can be used to 
either facilitate the surface attachment of the respective drug itself or to create a layer on top of 
a coating with a therapeutic compound to modulate the kinetics of its release. Among the 
multitude of possible applications, recent research activities are focused on two main 
directions: the equipment of implants with antibiotics and other compounds with antibacterial 
properties to prevent implant-related infections and the coating with anti-thrombogenic agents 
to prevent the formation of blood clots and thrombosis for implants with blood contact like 
vascular prostheses and stents. In principle, most of the plasma-based approaches used in 
these areas could also be applied with other drugs which have already been examined for 
drug-eluting implants, for example paclitaxel and everolimus (Butt et al., 2009), 
dexamethasone (Radke et al., 2004) or trapidil, probucol and cilostazol (Douglas, 2007) all 
aimed at reducing restenosis after implantation of vascular stents which is an emerging and 
clinically promising field for controlled drug release in biomaterials research. 
2.1 Implant surfaces with antibacterial properties 
The equipment of implants with antibacterial properties can be achieved either by attaching 
antibiotic substances or by creating surfaces which release metal ions which are known to 
have anti-infective effects. Polyvinylchloride, a polymer which is used for endotracheal 
tubes and catheters, was equipped with triclosan and bronopol, compounds with immediate 
and persistent broad-spectrum antimicrobial effects, after the surface was activated with 
oxygen plasma to produce more hydrophilic groups for effective coating (Zhang et al., 
2006). Experiments using Staphylococcus aureus and Escherichia coli demonstrated the 
effectiveness of these surfaces. Similarly, polyvinylidenfluoride used for hernia meshes was 
modified by plasma-induced graft polymerization of acrylic acid with subsequent binding 
of the antibiotic gentamycin (Junge et al., 2005). In addition to the microbiological 
examination of the gentamycin-releasing material, the in vitro and in vivo biocompatibility 
was examined by cytotoxicity testing and implantation into Sprague-Dawley rats for up to 
90 days, and no side effects on biocompatibility were observed. The fact that an implant 
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coating with a sustained release of gentamycin is effective against bacteria with no adverse 
effects on cellular proliferation was also confirmed by the evaluation of titanium implants 
with gentamycin grafted onto the surface of a plasma sprayed wollastonite coating (Li et al., 
2008). Wollastonite was previously found to be a promising material for bone tissue repair 
due to its high bonding strength to titanium substrates, its mechanical properties and its 
bioactivity and biocompatibility (Liu et al., 2008). 
Due to their well-known antibacterial effects, metals like silver, copper or tin are possible 
alternatives to classical antibiotic compounds as an effective and sustained release from 
coatings is possibly easier to achieve due to their small size. Similarly to gentamycin as 
mentioned before, silver has been used as a powder added to a plasma-sprayed wollastonite 
coating on titanium implants (Li et al., 2009). In comparison to a coating without silver, tests 
with Escherichia coli confirmed the antibacterial activity of the silver while an examination of 
osteoblast morphology revealed no obvious difference between both coatings. Furthermore, 
the release of silver was also examined for amino-hydrocarbon plasma polymer coatings 
(Lischer et al., 2011), after plasma immersion ion implantation into polyethylene (Zhang et 
al., 2008) and for silver nanoparticles bound to an allylamine plasma polymer thin film 
(Vasilev et al., 2010b). Similarly, the use of copper for antibacterial implant coatings has also 
been studied by plasma implantation into polyethylene (Zhang et al., 2007). The use of 
plasma immersion ion implantation is however not restricted to polymer materials as 
demonstrated by recent work on the application of this process for equipment of titantium 
surfaces with copper ions (Polak el al., 2010). Compared to controls, the implants created by 
this Plasma immersion ion implantation of copper reduced the number of methicillin-
resistant Staphylococcus aureus cultivated on the respective surfaces (Schröder et al., 2010a). 
Ion implantation can also be used for non-metals like fluorine which is of particular 
relevance for dental applications. This was examined with titanium, stainless steel and 
polymethyl methacrylate for fluorine alone (Nurhaerani et al., 2006) or with stainless steel 
for a combination of fluorine with silver (Shinonaga & Arita, 2009). 
2.2 Implant surfaces with reduced thrombogenicity 
Another field of interest for plasma applications is the coating of implants with anti-
thrombogenic agents. This is of special importance for vascular prostheses and stents which 
are in constant contact with blood. For these implants, thrombosis and blood clot formation 
are severe and potentially life-threatening complications. Classical anti-coagulants used for 
thrombosis prophylaxis and treatment include coumarin derivates like phenprocoumon for 
oral application as well as heparin which is physiologically found in the body and extracted 
for medicinal use from mucosal tissues of slaughtered meat animals and hirudin, originally 
from the European medical leech Hirudo medicinalis, for parenteral use. The Plasma-based 
attachment of heparin has for example been examined for stainless steel which is used in 
stents (Yang et al., 2010). For this application, a pulsed-plasma polymeric allylamine film 
with a high amino group density was created to subsequently immobilize heparin via its 
carboxylic groups and established coupling chemistry using 1-Ethyl-3-(3-
dimethylaminopropyl) carbodiimide and N-Hydroxysuccinimide. In a similar way, a 
heparin coating of polystyrene surfaces was achieved by preadsorption with undecylenic 
acid, a FDA-approved natural fungicide for skin disorders, followed by treatment with 
argon plasma and covalent immobilization of an albumin-heparin conjugate (van Delden et 
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al., 1997). Another example is the heparinization of polyurethane by low temperature 
plasma and grafting of poly(acrylic acid), water-soluble chitosan and heparin (Lin et al., 
2005). In addition to well-established anti-coagulants, the endothelial membrane protein 
thrombomodulin, a co-factor in the thrombin-activated anticoagulant pathway, has also 
been examined regarding plasma-based attachment on biomaterial surfaces. This 
application was studied for polytetrafluoroethylene, a common material for vascular 
prostheses, via CO2 plasma activation and subsequent vapour phase graft polymerization of 
acrylic acid (Vasilets et al., 1997; Sperling et al., 1997). Another surface modification which 
was examined for reduced thrombogenicity was plasma-induced graft polymerization of 2-
methacryloyloxyethyl phosphorylcholine on titanium alloy surfaces which resulted in 
reduced deposition and activation of platelets in subsequent in vitro experiments with ovine 
blood (Ye et al., 2009). 
2.3 Regulation of drug release by barrier layers 
In addition to plasma-assisted surface attachment of therapeutic compounds, plasma 
processes can also be used to create an over-coating which acts as a barrier to regulate the 
drug release. This application has for example been examined using daunomycin, an 
antibiotic substance, and rapamycin, a compound with immunosuppressive and anti-
proliferative effects which is used for example in stents to prevent excessive tissue growth, 
in combination with a plasma polymerized tetramethylcyclo-tetrasiloxane coating (Osaki et 
al., 2011). Changing the deposition time length resulted in different coating thickness which, 
like the molecular weight of the drug, was found to influence the drug-release rate. A 
comparable approach was used on polyetherurethane onto which a plasma-deposited 
poly(butyl methyacrylate) membrane with controlled porosity was applied to control the 
release of ciprofloxacin (Hendricks et al., 2000). Adhesion and colonization of Pseudomonas 
aeruginosa was evaluated to assess the antimicriobial effectiveness. 
Furthermore, an over-coating can also be applied to surfaces which release metal ions. For 
instance, the antibacterial surfaces created by plasma immersion ion implantation of copper 
as mentioned before were also treated with an additional layer of plasma-polymerized 
allylamine to regulate the Cu release and to modulate cellular adhesion and spreading. This 
combination reduced the antibacterial effects of the surface to some extent but did not 
completely disable it (Schröder et al., 2010a). On the other hand, the combined treatment 
also led to lower local inflammatory reactions after implantation into rats (Schlosser, 
unpublished data), highlighting the need to find an optimal balance between in vivo 
biocompatibility and sufficient antibacterial effects. Another study demonstrated that 
creation of thin films by plasma polymerization for controlled release of silver ions and 
traditional antibiotics is applicable to the surface of many different medical devices (Vasilev 
et al., 2010a). 
The use of an over-coating to regulate the release rate is not only possible for antibiotics but 
also for antithrombogenic agents. This has for example been studied for hirudin for which 
an additional layer of 2-hydroxyethyl methacrylate created by glow discharge plasma 
deposition on drug-loaded polyurethane matrices served as a diffusional barrier controlling 
the hirudin release kinetics depending on the plasma coating conditions (Kim et al., 1998). 
Of more general interest for the field of drug-releasing implants is a recent study which 
describes the use of liposomes, artificial vesicles enclosed by a lipid bilayer. Liposomes can 
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be used as drug containers by encapsulation of therapeutic compounds, in some cases 
additionally targeted to their site of action by antibodies, and potentially offer a wide range 
of applications. Covalent coating of liposomes onto stainless steel was achieved via 
radiofrequency glow plasma assisted creation of a thin film of acrylic acid characterized by 
surface carboxylic groups to which the liposomes were attached via formation of amide 
bonds (Mourtas et al., 2011). While the study was considered by the authors to be a proof of 
principle, the presented method seems to be a versatile approach due to possible changes of 
process parameters for the liposome immobilization procedure as well as regarding the 
choice of different drugs for encapsulation. 
3. Plasma-based surface functionalization 
Medical implants interact with their surrounding tissue in a complex manner. For example, 
a so called neointima layer is formed over time at the inner surface of vascular prostheses. 
Bone implants based on calcium phosphate possess osteoconductive and osteoinductive 
properties. Most importantly, all biomaterials are foreign to the body and the aim of acute 
and chronic inflammatory reactions which can persist for as long as the implant remains in 
the body. While short-term temporary implants which are removed some time after 
implantation should rather be inert, long-term implants intended for permanent presence in 
the recipient’s body should ideally possess bioactive properties to facilitate proper tissue 
integration. A multitude of different approaches has been examined with the aim to 
influence the interactions between biomaterials and the host tissue, for example by 
regulation of protein and cell attachment to improve the implant ingrowth and to reduce 
implant-related inflammation. Possible methods include for example the coating with 
different proteins, with biomembrane-derived phospholipids, with diamond-like carbon or 
ceramics or the attachment of chemical groups to create surfaces with a specific electric 
charge. Low-temperature plasmas have extensively been examined in vitro and in vivo for 
these applications. 
3.1 Creation of bioactive surfaces  
The cell-material and tissue-material interactions can be influenced by modifying the surface 
charge via chemical groups. For example, an enhanced osteoblast growth in vitro was 
observed for surfaces modified with plasma-polymerized 1-aminoheptane (Zhao et al., 
2011). The plasma-based deposition of acetaldehyde and allylamine polymer coatings on 
silicon and perfluorinated poly(ethylene-co-propylene) was found to influence the 
outgrowth of bovine corneal epithelial tissue for up to 21 days (Thissen et al., 2006). A 
treatment of Titanium samples with a comparable process called plasma-polymerized 
allylamine, based on the polymerization of allylamine after activation with a continuous 
wave oxygen-plasma, creates a positively charged amino group rich surface aimed at 
improving attachment of the negatively charged matrix substance hyaluronan. This coating 
was found to be advantageous concerning initial osteoblast adhesion and spreading (Nebe 
et al., 2007) and to have beneficial effects in vitro on the formation of focal adhesions as well 
as on cell morphology and spreading (Finke et al., 2007) and vinculin mobility (Rebl et al., 
2010) of osteoblasts. An in vivo examination in rats revealed no negative influence on the 
number of total and tissue macrophages, T cells and MHC class II antigen-presenting cells in 
the peri-implant tissue (Hoene et al., 2010). Furtheremore, it was demonstrated that the 
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plasma parameters influence the surface properties and thereby the host response. Samples 
with a lower plasma duty cycle (ratio of plasma on-time ton divided by the overall pulse 
duration ton + toff) resulted in a higher layer thickness and protein absorption as well as a 
lower oxygen uptake due to sonication in distilled water. Consequently, the hydrogel-like 
character of the plasma-polymerized allylamine films was probably more developed for the 
high duty cycle samples, resulting in an overall lower inflammatory response in vivo than 
for the implants created with a low duty cycle (Hoene et al., 2010). Similar results regarding 
enhanced cell adhesion were also obtained for a plasma consisting of a mixture of argon and 
ethylenediamine (Finke et al., 2011). A treatment of a hip prosthesis with this plasma 
process is exemplarily shown in Fig. 2. 
 
 
Fig. 2. Hip joint implant in low pressure plasma using a mixture of argon and 
ethylenediamine for cell adhesive coating  
In contrast to these positively charged NH2 films, a coating of Titanium implants with 
acrylic acid after similar plasma activation, called plasma-polymerized acrylic acid, results 
in a negatively charged COOH-group rich surface which was found to facilitate osteogenic 
differentiation by stimulation of mRNA expression of early (ALP, COL, Runx2) as well as 
late  (BSP, OCN) bone differentiation markers (Schröder et al., 2010b).  However, the long-
term inflammatory response in vivo caused by this coating were increased compared to 
uncoated controls (Schröder et al., 2010b), highlighting the difficult balance that improving 
one specific aspect of implant characteristics is often accompanied by adverse changes in 
other parameters. Furthermore, it illustrates the problem that the results of in vitro 
experiments on the one hand and in vivo studies on the other are often inconsistent due to 
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the complex nature of reactions in a living organism which can only partially and often 
inadequately be modelled using in vitro approaches. 
Similar to metals and metal alloys, cell attachment on polymers can also be modulated by 
plasma treatment. The application of glow-discharge plasma of mixed ammonia and oxygen 
on polytetrafluoroethylene surfaces reduced the hydrophobicity and increased the 
attachment of aorta endothelial cells (Chen et al., 2003). Furthermore, an oxygen plasma has 
been shown to improve surface attachment of mouse fibroblasts L-929 on thermoplastic 
polyetherurethane used for gastric implants (Schlicht et al., 2010). 
Low-temperature plasma can also be used to achieve immobilization of bioactive molecules. 
This was demonstrated for example by an oxygen plasma treatment to enhance the 
immobilization of simvastatin, which stimulates bone formation, onto Ti surfaces (Yoshinari et 
al., 2006). The deposition of thin film from ethylene plasma on Ti surfaces allows the chemical 
attachment of hydroxyethylmethacrylate onto Ti to improve the in vitro adhesion of mouse 
fibroblasts L-929 (Morra & Cassinelli, 1997). Albumin nanoparticles conjugated with a 
truncated fragment of fibronectin were directly patterned onto polymers to elicit adhesion and 
spreading of human mesenchymal stem cells and fibroblasts (Rossi et al., 2010). Stable coating 
of collagen type I onto two different metal alloys (Ti6Al4V, X2CrNiMo18) was achieved using 
a argon-hydrogen plasma and found to increase the viability and attachment of human 
osteoblast-like osteosarcoma cells SAOS-2 (Hauser et al., 2010), and coating of collagen onto 
silicone performed with an argon-oxygen plasma led to increased adhesion and viability of 
mouse fibroblasts 3T3 (Hauser et al., 2009). Poly(lactide-co-glycolide), a biodegradable 
polymer widely used as scaffold material for tissue engineering, was modified by oxygen 
plasma treatment followed by anchorage of cationized gelatine for improved attachment and 
growth of mouse fibroblasts 3T3 (Shen et al, 2007). 
A popular material for bioactive coatings on implants for bone replacement is calcium 
phosphate which is the main natural component in the bone matrix where it accounts for 
more than half of the bone weight. It exists in a variety of different chemical preparations 
differing in their atomic and ionic lattice configuration, their Ca:P ratio, the number and size 
of pores, and their surface area. One calcium phosphate preparation commonly used for 
biomaterials is hydroxyapatite (Ca10(PO4)6(OH)2) which is generally considered to be 
osteoconductive and osteoinductive (Walschus et al., 2009). Using a process called plasma 
spraying, it is possible to deposit thin and dense layers of hydroxyapatite onto metal 
implant surfaces (de Groot et al., 1987). Due to the well-established bioactive properties and 
good biocompatibility of hydroxyapatite, these coatings have been clinically used in 
dentistry and orthopedics since the mid 1980s (Tang et al., 2010). Furthermore, plasma 
spraying can also be used to create other layers like Ca-Si-Ti-based sphene ceramics (Wu et 
al., 2009), hydroxyapatite/ silica ceramics (Morks 2008), zirconia (Morks & Kobayashi 2008; 
Wang et al., 2010), yttria-stabilized zirconia (Wang et al., 2009) or hydroxyapatite/ yttria/ 
zirconia composites (Chang et al., 1997; Gu et al., 2004). One important advantage of 
plasma-sprayed coatings for biomaterials is the ability to precisely modify the 
microstructure by modulating the parameters of the plasma process (Khor et al., 2004; 
Huang et al., 2010) to study and improve microstructure-related tissue growth stimulation. 
3.2 Plasma-assisted vapour deposition of inert diamond-like carbon layers 
Another field of increasing interest which should be mentioned briefly in this chapter is the 
plasma-based coating of implants with diamond-like carbon for which plasma-assisted 
chemical vapour deposition is the most commonly used deposition method. Diamond-like 
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carbon layers can exhibit the typical diamond crystalline structure, an amorphous structure 
or a mixture of both (Schlosser & Ziegler, 1997). Furthermore, depending on the coating 
procedure, they can consist of pure carbon or contain other elements. Overall, diamond-like 
carbon films are characterized by an excellent mechanical stability and hardness, a high 
corrosion resistance as well as reduced tissue-material interactions and no detectable 
cytotoxicity (Schlosser & Ziegler, 1997). Particularly for implants where inertness of the 
surface is required, they are therefore an attractive option for coating of medical implants in 
a number of applications in reconstructive surgery and dentistry (Roy & Lee, 2007). 
Diamond-like carbon coatings have for example been examined for ureteral stents (Laube et 
al., 2007), orthodontic archwires (Kobayashi et al., 2007), joint implants (Thorwarth et al., 
2010) or cardiovascular stents (De Scheerder et al., 2000). 
4. Plasma sterilization 
Sterilization as the elimination of living microorganisms like bacteria, viruses and fungi, 
especially pathogenic agents, is an important aspect in biomaterials applications to prevent 
implant-related infections. Commonly used methods to achieve sterility include the treatment 
with heat, chemicals and irradiation. Each of those methods has its specific disadvantages and 
not all are equally usable for the sterilization of medical implants. For example, a heat 
treatment can lead to irreversible modifications of heat-labile materials and to denaturation of 
protein coatings. Irradiation with UV or gamma rays requires cost-intensive equipment with 
high safety requirements and can also cause irreversible modifications of proteins such as 
albumin and collagen used as sealing impregnation of vascular prostheses, as well as 
biomaterials like polymers. Chemical sterilization using for example ethylene oxide could 
result in residuals on the treated surface. Therefore, the application of low-temperature plasma 
processes as an alternative sterilization technique which is a gentle process from a physico-
chemical point of view has been the focus of ongoing research since several years. It is known 
that exposure to plasma effectively and irreversibly damages cells from different bacteria 
species like for example Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, Bacillus 
cereus or Bacillus subtilis (Bazaka et al., 2011). Especially for modified or functionalized 
biomaterials, sterilization with low-temperature plasma would therefore be an attractive 
option as it could be achieved as a secondary effect of plasma treatment aimed at other surface 
modification purposes (Bazaka et al., 2011). 
The application of plasma sterilization of heat-sensitive silicone implants has recently been 
demonstrated (Hauser et al., 2011). Similarly, sterilization of poly-L-lactide electrospun 
microfibers which can be used to repair tissue defects can effectively be achieved by 
hydrogen peroxide gas plasma which ensures sterility of the scaffolds and does not affect 
their chemical and morphological features (Rainer et al., 2010). Biodegradable polyester 
three-dimensional tissue engineering scaffolds which are particularly prone to 
morphological degeneration by high temperature and pressure were successfully sterilized 
with an argon-based radio-frequency glow discharge plasma (Holy et al., 2001), 
demonstrating the usefulness of plasma sterilization for damageable materials. Similar 
results were also obtained for starch based biomaterials for which a recent study found that 
treatment with oxygen plasma resulted in more hydrophilic surfaces compared to UV-
irradiation (Pashkuleva et al., 2010). Furthermore, both methods gave comparable results 
regarding osteoblast adherence, from which the authors concluded that plasma sterilization 
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as well as UV-irradiation improved the biocompatibility and can be used as cost-effective 
methods for sterilization.  
For metal implants, it was found that rapid and efficient sterilization of different alloys like 
X2CrNiMo18-15-3, Ti6Al7Nb und Ti6Al4V is possible with plasmas based on different gas 
mixtures such as argon/oxygen, argon/hydrogen and argon/nitrogen (Hauser et al., 2008). 
Sterilization of non-woven polyethylene terephthalate fiber structures for vascular grafts 
with either ethylene oxide or low temperature plasma resulted in comparable fibroblastic 
viability but a significantly higher TNF-α release, indicating activation of macrophages, for 
macrophages incubated on the fibres which were treated with ethylene oxide (Dimitrievska 
et al., 2011). Subcutaneous implantation into mice demonstrated inflammation accompanied 
by a foreign body reaction with no difference after 30 days between the samples treated 
with the two sterilization methods. A comparison of the effects of sterilization with gamma 
irradiation, ethylene oxide treatment, electron beam irradiation and plasma sterilization on 
the in vitro behaviour of polylactide fibres revealed that sterilization with both gamma and 
electron beam irradiation caused a decrease of the intrinsic viscosity while treatment with 
ethylene oxide and plasma sterilization had no pronounced effects on the sample properties 
(Nuutinen et al., 2002). These results also highlight the potential of plasma sterilization as a 
gentle alternative to other commonly used sterilization methods. However, it is not equally 
suitable for all materials as it might have adverse effects on relevant material properties. For 
example, demineralized bone matrix which was sterilized with low-temperature gas-plasma 
sterilization lost its osteoinductive capacity (Ferreira et al., 2001). 
Another application related to sterilization is the removal of surface contaminations. This is 
particularly important for residues like prion proteins which have contagious and 
pathogenic properties. The usefulness of plasma treatment for molecular-level removal of 
proteinaceous contamination was recently demonstrated for silicon and surgical stainless 
steel surfaces (Banerjee et al., 2010). 
5. Conclusions and outlook 
Low temperature plasmas offer a wide range of applications in biomaterials research to 
improve the clinical performance of medical implants by modifying their surface 
characteristics. In many cases, the use of plasmas facilitates modifications which are difficult 
or unable to achieve by conventional physical or chemical methods, like for example the 
stable attachment of molecules onto noble metal surfaces. The concise overview presented in 
this chapter demonstrates the potential of low temperature plasma processes for the precise 
modification of specific implant surface properties while retaining the overall characteristics 
of the material. The main aims of research in this field are to reduce implant-related 
complications like infections, thrombus formation and inflammation as well as to modulate 
the cell-material and tissue-material interactions for improved implant ingrowth. Another 
equally important area of research is the use of plasmas for sterilization. The studies which 
were presented here indicate that plasma processes are applicable for practically all 
commonly used biomaterials including metals, polymers, ceramics and composites, offering 
a wide range of clinical applications in all fields of reconstructive medicine. 
Given the versatility of low temperature plasma processes and the diverse nature of materials 
and clinical applications, it is difficult to predict future developments in this field. If there is 
any specific trend, then it is an increase in the number of studies which deal with 
biodegradable materials, reflecting an overall surge of interest in biomaterials research for this 
kind of materials. Another development is the use of increasingly sophisticated methods for 
surface analysis, making it possible to draw precise conclusions regarding relationships 
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between process parameters, surface characteristics and the biological response. Two 
important aspects in need of more research are on the one hand the aging-related surface 
changes of plasma-modified biomaterials and on the other hand their in vivo behaviour. Most 
of the studies discussed here used only in vitro methods to assess the biocompatibility. 
However, for the step from the lab into clinical practice it is essential to examine the in vivo 
biocompatibility by using appropriate animal models. There are several aspects of 
biocompatibility, both short- and long-term, which can not be adequately examined with in 
vitro methods like cell culture techniques. More detailed in vivo testing together with a better 
understanding of the influence of the plasma parameters on the physico-chemical material 
properties and on the response of cells, tissues and living organisms will ultimately turn 
currently promising research projects into clinical applications for improved implants. The 
increasing interest in the application of low-temperature plasmas in biomaterials science is 
illustrated by the formation of long-term and large-scale research projects, scientific centers 
and institutional networks in recent years, for example the Plasma Physics and Radiation 
Technology Cluster at the Eindhoven University of Technology in the Netherlands, the Center 
for Advanced Plasma Surface Technology (CAPST) in Korea, and the Campus PlasmaMed at 
the Leibniz Institute of Plasma Science and Technology Greifswald, the University of 
Greifswald and the University of Rostock in Germany. 
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